Internal Medicine · 2012 · 32 citations · 25 references
MedicineInfectious DiseasesNeurologyNeuroimmunologyNeuromuscular DisordersNeuropathologyAutoimmune Neurological DisordersDemyelinating DiseasesDemyelinating DisordersNeuropathology Of InfectionOptic NeuritisOptic NeuropathiesAquaporin-4 Antibody DiseaseAutoimmune MyelitisDemyelinating Lesion PathologyImmune-mediated DemyelinationNeuromyelitis Optica Spectrum Disorder-associated Optic NeuritisPeripheral Demyelinating NeuropathyPeripheral Neuropathy PathophysiologySensory Function Impairment
Neuromyelitis optica spectrum disorder (NMOSD) is characterized by optic neuritis or transverse myelitis with anti-aquaporin 4 (AQP4) antibodies (1). We herein present the case of a patient with NMOSD who also was affected with peripheral neuropathy. A 58-year-old woman developed gait disturbance and sensory impairment in the lower limbs. She exhibited longitudinally extensive transverse myelitis with anti-AQP4 antibodies. Nerve conduction studies showed demyelinating changes. Laboratory findings showed hepatitis-C virus (HCV) infection. Her peripheral neuropathy improved after immunotherapy. There have been no previous reports of NMO or NMOSD associated with neuropathy. The HCV infection or undetermined humoral factors other than the anti-AQP4 antibodies may have caused her peripheral neuropathy.
25
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Vanda A. Lennon, Dean M. Wingerchuk, Thomas J. Kryzer et al. · The Lancet · 2004 · 3.2K citations
Life Sciences, Immunology, Neurology +14
Sjögren's syndrome. Proposed criteria for classification
Robert I. Fox, Charles A. Robinson, John G. Curd et al. · Arthritis & Rheumatism · 1986 · 685 citations
Medicine, Immunology, Pathology +17
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Toshiyuki Takahashi, K. Fujihara, Ichiro Nakashima et al. · Brain · 2007 · 633 citations · Full text
Life Sciences, Immunology, Neurology +15